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Abstract
Background:  Different studies have shown insufficient blood pressure (BP) control in
hypertensive patients. Multiple factors influence hypertension management, and the quality of
primary care is one of them. We decided therefore to evaluate the effectiveness of a quality
improvement plan directed at professionals of Primary Health Care Teams (PHCT) with the aim
to achieve a better control of hypertension. The hypothesis of the study is that the implementation
of a quality improvement plan will improve the control of hypertension. The primary aim of this
study will be to evaluate the effectiveness of this plan.
Methods and design: Design: multicentric study quasi-experimental before – after with control
group. The non-randomised allocation of the intervention will be done at PHCT level. 
Setting: 18 PHCT in the Barcelona province (Spain). 
Sample: all patients with a diagnosis of hypertension (population based study). Exclusion criteria:
patients with a diagnosis of hypertension made later than 01/01/2006 and patients younger than 18
years. 
Intervention: a quality improvement plan, which targets primary health care professionals and
includes educational sessions, feedback to health professionals, audit and implementation of
recommended clinical practice guidelines for the management of hypertensive patients. 
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Measurements: age, sex, associated co-morbidity (diabetes mellitus type I and II, heart failure and
renal failure). The following variables will be recorded: BP measurement, cardiovascular risk and
antihypertensive drugs used. Results will be measured before the start of the intervention and
twelve months after the start of the study. 
Dependent variable: prevalence of hypertensive patients with poor BP control. 
Analysis: Chi-square test and Student's t-test will be used to measure the association between
independent qualitative and quantitative variables, respectively. Non-parametric tests will be used
for the analysis of non-normally distributed variables. Significance level (α) will be set at < 0.05.
Outcomes will be analysed on an intention-to-treat basis.
Discussion: The implementation of a quality improvement plan might benefit the coordination of
different professionals of PHCTs and may also improve blood pressure control.
Trial Registration: This protocol has been registered at clinicaltrials.gov with the ID number MS:
1998275938244441.
Background
Hypertension is one of the most important risk factors of
cardiovascular morbidity and mortality and one of the
main reasons for seeking medical attention in primary
care, especially in the elderly population [1-5]. The preva-
lence of hypertension in Spain ranges from 20 to 47% in
the population older than 20 years and up to 65% in the
population above 60 years of age [2,4].
Since hypertension is a powerful risk factor of survival
from cardiovascular disease, its control is highly impor-
tant. In Spain, one out of two deaths of cardiovascular ori-
gin that occur yearly in patients above 50 years of age can
be attributed to high blood pressure, and in 90% of cases
to hypertension [6].
Patients with uncontrolled hypertension usually present
with other cardiovascular risk factors, more target organ
damage, and an increased number of cardiovascular dis-
eases associated with their condition [7,8].
A number of studies carried out both in Europe and in
the United States have shown that blood pressure (BP)
control in hypertensive patients is suboptimal [2,9-15].
In Spain a study revealed that BP was properly controlled
only in 33.5% of the patients older than 65 years [2]. In
a separate study that took place in Catalonia (specifically
in the Àmbit Centre of the Catalan Institute of Health
(ICS) where we aim to develop this project), the propor-
tions of properly controlled hypertensive patients above
15 years of age with and without diabetes were 23.9%
and 44.3%, respectively [16]. Although higher than
those reported in other studies [7,10,17], these propor-
tions remain sub-optimal. However, a recent study of the
hypertensive population in Spain indicates an improv-
ing trend in the control of this condition [10].
Different factors have been associated with an inadequate
control of hypertension [2,9-15,18-25]:
1. Patient-related factors: therapeutic adhesion, age,
lifestyle (alcoholism, sedentarism), body-mass index,
number of visits to the doctor during the past year and
the understanding of their condition, among others.
2. Treatment-related factors: it is becoming increas-
ingly obvious that for many patients the use of mono-
therapy is not sufficient to control BP; other
concomitant treatments the patient might be receiving
can interfere with antihypertensive drugs; the specific
antihypertensive drug chosen taking into account the
degree of hypertension and the associated conditions.
3. Factors related to the clinical management: the tech-
nique to measure BP and the time of day this measure-
ment is done (morning, afternoon, before or after
medication), as well as the clinical management of
uncontrolled hypertensive patients. It is equally essen-
tial to follow clinical guidelines to avoid clinical iner-
tia, such as when there is no treatment intensification
in uncontrolled hypertension even when there is good
therapeutic compliance.
4. Factors related to the equipment used to measure
the BP, such as the type of monitor (aneroid, auto-
matic, mercury), its precision, validation and calibra-
tion.
Care delivered by primary health centres is one of the fac-
tors that can influence the control of hypertensive patients
[26]. The implementation of some measures that affect
both patients and health professionals are necessary if a
better control of hypertension is intended. Therefore, anBMC Public Health 2009, 9:89 http://www.biomedcentral.com/1471-2458/9/89
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improvement is required in the following areas: informa-
tion and knowledge about the techniques to measure BP;
the follow-up of patients; analysis of patient compliance
and of the implementation of treatment guidelines, where
continued education and patient positive feed-back are
considered crucial [12,27].
Based on the published medical literature, a research
project that considers an integral, multicentric and multi-
disciplinary intervention at primary health care level with
an impact on daily practices of both clinicians and nurses,
may improve the control of hypertension. Previous stud-
ies describing the implementation of interventions based
on methods to improve the quality of health care have
been shown to have a positive impact on health [28]. Sub-
sequently, we believe it is important to assess the effective-
ness of a programme to better the quality of health care,
addressed to primary health care professionals with the
aim to optimise the control of BP in hypertensive patients.
Hypothesis
The hypothesis that underlies this project states that the
implementation of a plan for quality improvement at
PHC level addressed to primary health care professionals
will ameliorate the management and control of hyperten-
sive patients.
Aims
Primary aim
to assess the effectiveness of a programme directed to
health professionals which intends to improve the quality
of health care to optimise the control of BP in hyperten-
sive patients.
Secondary aims
to assess the impact on uncontrolled hypertension of the
presence or absence of co-morbidities and the number of
antihypertensive drugs prescribed.
Methods and design
Study design
The study will be a multicentric non-randomised control-
led quasi-experimental pre-post intervention study to
assess the effectiveness of a quality improvement plan at
PHC level (see figure 1). The non-randomised allocation
of the subjects will be decided at the PHCTs.
Setting
Intervention group: 5 PHCTs of the Primary Health Care
area of Cerdanyola-Ripollet (ICS) with 135,505 inhabit-
ants in the catchment area at the onset of the study.
Control group: 13 PHCTs of the Primary Health Care area
of Sabadell (ICS) with 269,727 inhabitants in the catch-
ment area at the onset of the study.
Both groups are comparable in terms of population char-
acteristics and socio-economical level. Availability of
computerised clinical records in the PHCTs before January
2005 will be an inclusion criterion.
Both groups of health professionals (control and interven-
tion) have been informed about the nature of the study,
and have given a verbal consent and agreement to partici-
pate in the study.
Study population
This is a population-based study that will include all
patients diagnosed with hypertension.
Exclusion criteria:
1. Patients diagnosed with hypertension after January
1st, 2006.
2. Patients under 18 years of age.
3. Patients with a diastolic blood pressure (DBP)
higher than systolic blood pressure (SBP) as recorded
in the clinical records.
Definition of uncontrolled hypertension
1. SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg. In
patients with diabetes, heart failure or renal failure,
SBP ≥ 130 mmHg and/or DBP ≥ 85 mmHg. In all cases
the values will be taken from the measurements
recorded at the patient's last visit to the primary health
centre.
2. Absence of any recorded BP measurement in the
computerised clinical record within the past 12
months.
Measurements
In addition to age and sex, and to ensure the comparabil-
ity of the groups studied, the following variables will be
collected: co-morbidities associated with hypertension
(presence of diabetes mellitus type I or II, heart failure or
renal failure), cardiovascular risk assessment according
to the Framingham tables [29], the presence of cardio-
vascular events, and duration of hypertension. The fol-
lowing dependent and independent variables will be
collected from the control and intervention groups: BP
measurement, register of cardiovascular risk in PHC pre-
vention, presence of a cardiovascular event, participation
in health care education, number of BP readings within
the past 12 months, and treatments received. Therapeu-
tic compliance will be evaluated by the Morisky-Green
test [30], the self-report compliance Haynes-Sackett test
[31], and searching the computer databases for pharma-
ceutical prescription.BMC Public Health 2009, 9:89 http://www.biomedcentral.com/1471-2458/9/89
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General Outline of the Study Figure 1
General Outline of the Study.
Pre-intervention phase (change of 
BP monitors and in the e-CAP)
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Exclusion criteria
Control group -13 PHCT (regular 
care) (269,727 inhabitants) 
Intervention group - 5 PHCT
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16,422 Hypertensive patients 35,220 Hypertensive patients
Patients included
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Intervention phase 
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Dependent or outcome variable
In agreement with the main aim of this study, the depend-
ent or main outcome variable will be good control of
hypertension as a dichotomous variable (yes/no) based
on SBP and DBP records over the last 12 months, or alter-
natively, the last values of SBP and DBP readings at the
time the data is analysed.
Independent variables and effect modifiers
The association of the following independent variables
with the main dependent variable will be assessed: age,
sex, treatment with antihypertensive drugs (yes/no),
number of antihypertensive drugs, co-morbidities (yes/
no), assessment of therapeutic compliance (yes/no),
health education (yes/no), cardiovascular risk assessment
according to the Framingham tables, duration of hyper-
tension, and number of SBP and DBP readings within the
past 12 months.
Intervention
The study intervention will be the implementation of a
plan of quality improvement addressed to health profes-
sionals in PHCTs. The quality improvement plan consists
of the following phases:
1.  Pre-intervention phase (12 months): in order to
ensure that hypertension is diagnosed under the same
conditions in both the intervention and the control
groups, the following actions will take place:
a) Non-validated blood pressure monitors will be
removed from the PHCT examination rooms. This
will allow us to standardise the equipment used to
measure BP in both the control and the interven-
tion groups. The model used in this study will be a
digital Omron-6 blood pressure monitor, which is
the model approved and recommended in the Cat-
alan Institute of Health (ICS) hypertension clinical
guidelines.
b) The software used to store computerised clinical
records will be modified to allow health profes-
sionals to adequately enter specific data related to
hypertensive patients (such as the control arm or
the results from the Morisky-Green therapeutic
adhesion evaluation test). This software is used by
all health professionals working for the ICS, thus it
will be used by health care professionals in the
PHCTs of both the intervention and the control
groups.
c) Make the Catalan Institute of Health (ICS)
guidelines on hypertension accessible to health
professionals. These are the reference clinical
guidelines for all health professionals that will par-
ticipate in this study.
2. Second phase (training, 10 months): a programme
has been designed to train health professionals of
PHCTs (doctors and nurses) on how to diagnose
hypertension correctly, the technique required to ade-
quately measure BP, and how to enter patient data in
computerised clinical records. This programme will be
delivered through training seminars and workshops.
Training material, such as posters and leaflets with
decision-making algorithms as recommended by the
ICS clinical guidelines, will be made available to par-
ticipants. These workshops will be carried out by
trained professionals (doctors and nurses) from the
same PHCTs that participate in the study. There will be
a workshop for each of the participating PHCTs on
each of the topics described above. By the end of the
programme a total of 8 workshops will have taken
place at each of the participating PHCTs.
3. Third phase (intervention, 13 months): the inter-
ventions carried out during this phase will aim at iden-
tifying uncontrolled hypertensive patients and act on
them to improve the control of their condition. This
will be accomplished by:
a) Every 6 months health professionals will receive
feedback on uncontrolled hypertensive patients
with individualised information about the degree
of control and antihypertensive treatment. These
data will be retrieved from the computerised clini-
cal records. In collaboration with the administra-
tive staff a specific track to get these patients an
appointment to see a doctor or nurse will be
devised. Patients with uncontrolled hypertension
that are not on any antihypertensive drug will get
an appointment to see the doctor and to evaluate
if antihypertensive treatment is indicated. Patients
receiving antihypertensive drugs will get an
appointment with the nurse to assess adhesion to
treatment and compliance with the recommended
hygienic and dietetic measures. Improvement
strategies will be devised if patients fail to comply
with these measures. Examples of such strategies
would be the implementation of drug dosing
methods that remind patients to take the medica-
tion, the improvement of communication with
patients to increase the understanding of the treat-
ment they receive, and detection of adverse effects
that may decrease therapeutic compliance.
Patients with good therapeutic compliance will be
referred to the doctor who will assess the pharma-
cological treatment (drug associations and interac-
tions) according to the current clinical guidelines.
b) An audit will be undertaken to assess the imple-
mentation of the improvement plan and the adhe-
sion to the recommended clinical guidelines, i. e.BMC Public Health 2009, 9:89 http://www.biomedcentral.com/1471-2458/9/89
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retrieval every six months of patient information
from computerised clinical records to generate
indicators of study protocol adhesion and dissem-
ination amongst health professionals.
c) The dissemination of the data to health profes-
sionals and preliminary analysis will be coordi-
nated by the research team.
d) Support Team: each PHCT will have a doctor
and a nurse that will provide support to the rest of
professionals of the PHCT on any aspect of the
programme implementation. This team will also
facilitate the communication and coordination
with the research team.
4. Fourth phase (evaluation of the implementation of
a quality improvement plan at 4 months): after the
conclusion of the third phase a pre-post treatment
analysis will be carried out to evaluate the effective-
ness of the quality plan. The results from this analysis
will be compared to those for the control group during
the same period. Figure 2 shows the time line for the
implementation of the different phases.
Control group
Health professionals for the control group use the same
software to enter patient data in computerised clinical
records and follow the same clinical guidelines for the
management of hypertensive patients as the intervention
group. The follow up of hypertensive patients will be done
as usual in the PHC centres, though health professionals
will not receive any feedback on the adequacy of the con-
trol of their patients.
Analytical plan
Data will be reported according to the CONSORT state-
ment for reporting of cluster randomised trials [32] and
comparisons will be based on intention-to-treat.
A baseline description and comparison of the two groups
will be carried out in relation to the main variables stud-
ied. Student's t-test and Mann-Whitney U-test (according
to the frequency distribution of the variables studied) will
be used to compare the means of the two groups. ANOVA
will be used to compare means when more than two cat-
egories exist. Chi-square test or chi-square for trend will be
used to compare proportions for categorical variables.
Logistic regression analysis will be carried out to model
the association of the dependent variable (uncontrolled
hypertension) with the independent variables selected
from the univariate comparisons. All analyses will be
adjusted for potential confounders and the relevant clini-
cal variables. The analysis will be done with SPSS version
15 for Windows and performed at the 95% confidence
level (two-sided).
The quality improvement plan will be considered effective
if at least an increase in 10% is observed in the proportion
of hypertensive patients adequately controlled compared
Timetable Figure 2
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with the baseline proportion observed in the intervention
group.
Ethical considerations
The study will be performed following good clinical prac-
tice (GCP) guidelines and complying with the Declaration
of Helsinki principles. The study protocol has received
institutional review board approval (Ethical Clinical
Committee at the IDIAP Jordi Gol).
Discussion
Previous studies have shown that the implementation of
multifactorial programmes for the management of differ-
ent conditions have a positive impact on health [28,33].
The aim of the INCOTECA Project is to create a pro-
gramme to manage hypertension and to set up a working
routine within PHCTs to improve the health of hyperten-
sive patients and to evaluate subsequently its effective-
ness.
A population-based quality improvement plan to identify
and resolve problems that not only targets daily practices
of doctors and nurses but also teams up with administra-
tive staff at health centres and addresses the main factors
associated with a poor control of hypertensive patients is
likely to have a positive impact in the control of this con-
dition. Moreover, it is expected that it will eventually alle-
viate the health burden caused by these patients.
The quality improvement plan is a multidisciplinary pro-
gramme that intends to involve the participation of doc-
tors and nurses as well as pharmacists and administrative
staff. This plan includes a number of measures that should
affect various aspects of patient management in the
PHCTs, such as structural measures (optimisation of the
equipment for patient follow-up), organisational meas-
ures (specific plan to schedule appointments for uncon-
trolled hypertensive patients), educational measures (a
training plan for health care staff) and measures that affect
clinical practice (assessment of therapeutic compliance
and health education for patients with poorly controlled
hypertension).
The main limiting factors to assess the effectiveness of this
plan are:
- Variability in the implementation and data entry in compu-
terised clinical records: the use of standardised software to
enter patient data in computerised clinical records is not
occurring at the same pace in the different PCHTs that will
participate in this study. In order to minimise this prob-
lem, it will be required as part of the inclusion criteria to
participate in this study that the PHCTs have been using
computerised clinical records since January 2005 to give
health professionals in these teams sufficient time to
familiarise themselves with this tool and to have accrued
sufficient data to carry out the improvement plan.
- Variability in the technique to measure BP: since different
health professionals will be measuring BP in the patients
for the duration of the study, a certain degree of inter-
observer variability will be unavoidable. To minimise this
variability, all health professionals will receive training on
the technique to measure BP recommended by the refer-
ence clinical practice guidelines. Similarly, health profes-
sionals will be offered the possibility to attend training
workshops to unify criteria for BP measurement. To fur-
ther reduce the possibility of overlap between the control
and intervention groups, the PHCTs that will participate
in the study have been selected from different PHC
administrative areas.
In conclusion, the implementation and evaluation of the
effectiveness of a quality improvement plan may create a
working routine in PHCTs that will improve the degree of
control of the hypertensive patients and eventually,
improve the health of the population.
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